Acknowledgements
We thank Dr. Thomas and Prof. Upadhyaya (Institute of Medical Genetics,
Cardiff, United Kingdom), Prof. Yoshimura (Keio University, Japan),
Prof. Scheffzek (Medical University of Innsbruck, Austria), Prof.
Elgersma (Erasmus Medical Center, The Netherlands) and Prof. Zwartkruis
(University of Utrecht, The Netherlands) for providing plasmid
constructs. Jacqueline Boonman, Paul van den Berg, Astrid Dorhout, Femke
Hendriks and Willemieke Nobel and Sandra van der Sluijs - de Heer are
thanked for technical assistance and data curation. We thank Dr. van
Dooren and Dr. van de Laar (Erasmus Medical Center, The Netherlands),
Dr. Lesnik and Dr. Moghadasi (Leiden University Medical Center, The
Netherlands), Dr. Sinnema (Maastricht University Medical Center, The
Netherlands), Dr. Corsten (University Medical Center Groningen, The
Netherlands), Dr. Plomp (Amsterdam University Medical Center, The
Netherlands), Dr. Zekveld-Vroon (University Medical Center Utrecht, The
Netherlands) and Dr. Spruijt (Radboud University Medical Center, The
Netherlands) for providing patient samples and information.
This research is supported (not financially) by the European Reference
Network on Genetic Tumour Risk Syndromes (ERN GENTURIS)—Project ID No
739547. ERN GENTURIS is partly co-funded by the European Union within
the framework of the Third Health Programme “ERN-2016—Framework
Partnership Agreement 2017–2021”.